AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

If the trial design doesn't cause regulatory issues, the results could reshape how muscle-invasive bladder tumors are treated ...

A targeted immunotherapy being developed by iTeos Therapeutics and GSK, it was reported at #ESMO, delivered promising ...

A new therapy approved by the FDA is one of the first major brain tumor breakthroughs in decades, say neuro-oncologists.

I coined the term “Typo-gate” to describe the misguided dustup Alnylam Pharmaceuticals executives instigated last Friday when they asserted cardiologist Sarah Cuddy made mistakes during her ...

Pfizer reported at #ESMO that an experimental antibody helped cancer patients with a condition known as cachexia.

One of the big presentations of this year’s ESMO (at least in our view) comes tomorrow morning bright and early. David Spigel ...

BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...

A growing number of people with type 1 diabetes are becoming overweight or obese, in part because insulin can cause weight ...

Mystery H5 flu case had a close contact who was ill at same time; CDC hopes blood tests will show if there was a connection.

For years, health insurers battled to gain market share in the lucrative privatized Medicare program. Now, the opposite is ...

A common immunotherapy approach helped stave off disease progression in patients with a form of anal cancer that is caused by ...